当前位置:首页 - 行情中心 - 海利生物(603718) - 财务分析

海利生物

(603718)

  

流通市值:48.28亿  总市值:48.78亿
流通股本:6.49亿   总股本:6.56亿

海利生物(603718)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.18亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益172680.15万元,未分配利润56652.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产183332.25万元,负债10652.10万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入61,792,980.19271,039,818.26174,428,026.55107,598,422.2
营业总成本41,355,751.57241,171,112.08210,114,237.84132,630,744.76
营业利润20,928,778.23174,526,297.07-27,413,235.16-18,237,339.45
利润总额20,991,005.58208,117,455.787,277,269.6416,482,302.99
净利润17,937,326.16181,635,596.0115,408,989.9810,376,109.43
其他综合收益-2,571,231.121,568,638.59-8,903,502.5
综合收益总额17,937,326.16184,206,827.1316,977,628.571,472,606.93
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计678,355,838.27691,774,180.511,169,792,575.23523,376,933.68
非流动资产合计1,154,966,709.191,135,065,039.03453,923,093.871,079,772,801.07
资产总计1,833,322,547.461,826,839,219.541,623,715,669.11,603,149,734.75
流动负债合计82,469,616.31100,246,459.34371,043,389.44371,416,208.7
非流动负债合计24,051,416.0423,399,272.4427,002,181.0722,579,465.97
负债合计106,521,032.35123,645,731.78398,045,570.51393,995,674.67
归属于母公司股东权益合计1,577,050,799.051,560,478,382.761,272,862,793.231,256,089,662.68
股东权益合计1,726,801,515.111,703,193,487.761,225,670,098.591,209,154,060.08
负债和股东权益合计1,833,322,547.461,826,839,219.541,623,715,669.11,603,149,734.75
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计49,985,443.39250,340,376.71166,910,098.43116,018,841.34
经营活动现金流出小计55,585,351.4203,867,285.99145,227,574.52104,351,966.01
经营活动产生的现金流量净额-5,599,908.0146,473,090.7221,682,523.9111,666,875.33
投资活动现金流入小计140,775,376.481,362,892,236.85559,112,248.43246,185,168.83
投资活动现金流出小计120,680,760.441,324,553,935.19594,939,464323,387,496
投资活动产生的现金流量净额20,094,616.0438,338,301.66-35,827,215.57-77,202,327.17
筹资活动现金流入小计-837,990,640.4758,413,42935,000,000
筹资活动现金流出小计10,517,452.91711,699,044.8103,833,995.7674,386,308.36
筹资活动产生的现金流量净额-10,517,452.91126,291,595.67-45,420,566.76-39,386,308.36
汇率变动对现金及现金等价物的影响-236,827.9610,304,326.17-5,721.113,020.5
现金及现金等价物净增加额3,740,427.16221,407,314.22-59,570,979.53-104,918,739.7
期末现金及现金等价物余额362,240,931.99358,500,504.8377,522,211.0832,174,450.91
TOP↑